Iversen E - Search Results

1

Pharmacogenetic testing of CYP2D6, CYP2C19 and CYP2C9 in Denmark: Agreement between publicly funded genotyping tests and the subsequent phenotype classification.

Baltzer Houlind M, Hansen L, Iversen E, Rasmussen HB, Larsen JB, Jørgensen S, Dalhoff K, Damkier P, Walls AB, Vermehren C, Andersen TRH, Kallemose T, Christrup L, Westergaard N. Baltzer Houlind M, et al. Among authors: iversen e. Basic Clin Pharmacol Toxicol. 2024 May;134(5):756-763. doi: 10.1111/bcpt.13990. Epub 2024 Feb 25. Basic Clin Pharmacol Toxicol. 2024. PMID: 38403838 No abstract available.

2

Kidney function estimates using cystatin C versus creatinine: Impact on medication prescribing in acutely hospitalized elderly patients.

Iversen E, Bodilsen AC, Klausen HH, Treldal C, Andersen O, Houlind MB, Petersen J. Iversen E, et al. Basic Clin Pharmacol Toxicol. 2019 Apr;124(4):466-478. doi: 10.1111/bcpt.13156. Epub 2018 Dec 7. Basic Clin Pharmacol Toxicol. 2019. PMID: 30372593 Free article.

3

Differences in Kidney Function Estimates Based on Creatinine and/or Cystatin C in Non-Traumatic Amputation Patients and Their Impact on Drug Prescribing.

Aakjær M, Houlind MB, Treldal C, Ankarfeldt MZ, S Jensen P, Andersen O, Iversen E, Christrup LL, Petersen J. Aakjær M, et al. Among authors: iversen e. J Clin Med. 2019 Jan 14;8(1):89. doi: 10.3390/jcm8010089. J Clin Med. 2019. PMID: 30646571 Free PMC article.

4

Elevated suPAR Is an Independent Risk Marker for Incident Kidney Disease in Acute Medical Patients.

Iversen E, Houlind MB, Kallemose T, Rasmussen LJH, Hornum M, Feldt-Rasmussen B, Hayek SS, Andersen O, Eugen-Olsen J. Iversen E, et al. Front Cell Dev Biol. 2020 Jun 12;8:339. doi: 10.3389/fcell.2020.00339. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32596235 Free PMC article.

5

Using soluble urokinase plasminogen activator receptor to stratify patients for medication review in the emergency department.

Bengaard AK, Iversen E, Kallemose T, Juul-Larsen HG, Rasmussen LJH, Dalhoff KP, Andersen O, Eugen-Olsen J, Houlind MB. Bengaard AK, et al. Among authors: iversen e. Br J Clin Pharmacol. 2022 Feb;88(4):1679-1690. doi: 10.1111/bcp.14982. Epub 2021 Aug 2. Br J Clin Pharmacol. 2022. PMID: 34242432 Free article.

6

Utility of suPAR and NGAL for AKI Risk Stratification and Early Optimization of Renal Risk Medications among Older Patients in the Emergency Department.

Walls AB, Bengaard AK, Iversen E, Nguyen CN, Kallemose T, Juul-Larsen HG, Jawad BN, Hornum M, Andersen O, Eugen-Olsen J, Houlind MB. Walls AB, et al. Among authors: iversen e. Pharmaceuticals (Basel). 2021 Aug 25;14(9):843. doi: 10.3390/ph14090843. Pharmaceuticals (Basel). 2021. PMID: 34577543 Free PMC article.

7

Medicines Reconciliation in the Emergency Department: Important Prescribing Discrepancies between the Shared Medication Record and Patients' Actual Use of Medication.

Andersen TS, Gemmer MN, Sejberg HRC, Jørgensen LM, Kallemose T, Andersen O, Iversen E, Houlind MB. Andersen TS, et al. Among authors: iversen e. Pharmaceuticals (Basel). 2022 Jan 26;15(2):142. doi: 10.3390/ph15020142. Pharmaceuticals (Basel). 2022. PMID: 35215255 Free PMC article.

8

Performance of the Cockcroft-Gault, Modification of Diet in Renal Disease, and new Chronic Kidney Disease Epidemiology Collaboration equations without race in older acute medical patients.

Iversen E, Bengaard AK, Andersen A, Kallemose T, Damgaard M, Hornum M, Feldt-Rasmussen B, Andersen O, Houlind MB. Iversen E, et al. Kidney Int. 2022 May;101(5):1087-1088. doi: 10.1016/j.kint.2022.02.016. Kidney Int. 2022. PMID: 35461603 No abstract available.

9

Machine Learning to Identify Patients at Risk of Inappropriate Dosing for Renal Risk Medications: A Critical Comment on Kaas-Hansen et al [Letter].

Houlind MB, Iversen E, Jawad BN, Kallemose T, Hornum M. Houlind MB, et al. Among authors: iversen e. Clin Epidemiol. 2022 Jun 9;14:763-764. doi: 10.2147/CLEP.S369602. eCollection 2022. Clin Epidemiol. 2022. PMID: 35707499 Free PMC article. No abstract available.

10

Soluble urokinase plasminogen activator receptor and decline in kidney function among patients without kidney disease.

Iversen E, Kallemose T, Hornum M, Bengaard AK, Nehlin JO, Rasmussen LJH, Sandholdt H, Tavenier J, Feldt-Rasmussen B, Andersen O, Eugen-Olsen J, Houlind MB. Iversen E, et al. Clin Kidney J. 2022 Feb 21;15(8):1534-1541. doi: 10.1093/ckj/sfac048. eCollection 2022 Aug. Clin Kidney J. 2022. PMID: 35892012 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

286 results

Search Page